Organization Overview
Alternative names
anti-psma car nk cells (1 trial)
autologous cd19/cd22 chimeric antigen receptor t-cells (1 trial)
autologous mesenchymal stem cell-derived neural progenitors (1 trial)
Carcinoma, Ovarian Epithelial (Phase 1)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 1)
Multiple Myeloma (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Ovarian Neoplasms (Phase 1)
Parkinson Disease (Phase 1)
Prostatic Neoplasms (Phase 1)
Stroke (Phase 1)